EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark DIAMUCIN was filed as Word mark on 12/02/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/25/2014.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 012390472 |
| Application date | December 2, 2013 |
| Publication date | January 16, 2014 |
| Entry date | April 25, 2014 |
| Expiration date | December 2, 2023 |
Trademark owner
Masonic Buildings Water Street
IM8 1RD Ramsey
IM
IM8 1RD Ramsey
IM
Trademark representatives
Lehel Carré Gewürzmühlstrasse 11
80538 München
DE
goods and services
1
Chemical and/or biological compositions and products used in science and industry; In particular enzymatic compositions and products for scientific purposes in the fields of molecular biology and protein biochemistry; Chemical and/or biological compositions and products for the analysis and characterisation of gene expression patterns in human or animal organisms, in particular for the analysis and characterisation of genes and gene products using quantitative measuring methods, in particular using quantitative real-time polymerase chain reaction (RT-PCR); Chemical and/or biological compositions and products for use in basic research and medicine, in particular in scientific laboratories and clinics
5
Pharmaceutical compositions and products for medical or veterinary purposes, in particular enzymatic compositions and products for medical or veterinary purposes, in particular for use in medicine, medical technology and/or the clinical diagnosis of human or animal organisms, in particular for use with human patients, in particular for analysis of the state of health of cancer patients and/or patients suspected of having cancer, in particular for verifying marker genes, in particular for verifying the gene expression of breast cancer marker genes and for the regulation thereof in response to therapy treatments, in particular for verifying the gene expression prior to and/or after therapeutic treatment of the patient and for diagnosis of the state of health
44
Medical and diagnosis services, in particular medical and diagnosis consultancy, in particular in the field of patient treatment and disease diagnosis, in particular medical analyses in connection with the treatment of individuals; In particular in connection with services rendered by expert medical personnel, doctors, veterinary surgeons and/or psychoanalysts, in particular in clinics and/or medical practices; In particular molecular biological analyses in the field of clinical tumour analysis and the analysis of tumour therapy applications; Pharmaceutical and medical consultancy and services in the field of tumour diagnosis and therapy tolerance, in particular in connection with cancer therapy, in particular in connection with the analysis and diagnosis of breast cancer in human patients, in particular in connection with the analysis of the gene expression patterns of breast cancer marker genes prior to and after therapy applications
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| October 3, 2024 | Extension, Trade mark expired | ||
| September 18, 2024 | Change Representative, Published | ||
| February 21, 2022 | Change Representative, Published | ||
| January 16, 2019 | Change Representative, Published | ||
| January 16, 2019 | Change Representative, Published |
ID: 11012390472